PATENT AND TRADEMARK OFFICE ISSUES NOTICE: GRANT OF INTERIM EXTENSION OF THE TERM OF U.S. PATENT NO. 8,877,798; CENTANAFADINE HYDROCHLORIDE

WASHINGTON, July 23 -- Patent and Trademark Office has issued a notice called: Grant of Interim Extension of the Term of U.S. Patent No. 8, 877, 798; Centanafadine Hydrochloride.

The notice was published in the Federal Register on July 23 by Stefanos Karmis, Acting Deputy Commissioner for Patents, United States Patent and Trademark Office.

Summary: The United States Patent and Trademark Office has issued an order granting a one-year interim extension of the term of U.S. Patent No. 8, 877, 798 ('798 patent).

For more information, contact Raul Tamayo, Senior Legal Advisor, Office of Patent Legal Administration, at 571-272-7728 or [e-mail].

The full text of the notice can be found at: http://www.gpo.gov/fdsys/pkg/FR-2026-07-23...